Elon Musk’s brain technology company Neuralink announced on Monday its approval to initiate a new feasibility study featuring its brain implant and an experimental robotic arm. This study builds on the company’s PRIME trial, which evaluates the safety of Neuralink’s wireless brain-computer interface and its advanced surgical robot.
The primary objective is to test the implant’s efficacy in helping quadriplegic patients—individuals suffering from complete or partial paralysis—control external devices purely through their thoughts.
Expanding Research Scope
Neuralink plans to include participants from the ongoing PRIME trial in this new feasibility study, as confirmed in a statement on the social media platform X (formerly Twitter). Both the U.S. Food and Drug Administration (FDA) and Neuralink have yet to release further details about this study.
Last week, Neuralink received regulatory approval from Health Canada to initiate trials in the country. Canadian neurosurgeons collaborating with Neuralink aim to recruit six patients with paralysis for the study.
Progress in the United States
In the U.S., Neuralink has already implanted its device in two trial patients. The first patient has successfully used the implant to perform various tasks, including playing video games, browsing the internet, posting on social media, and moving a cursor on their laptop.
The second patient has also reported promising results, using the implant to play video games and learn 3D design techniques. Neuralink has expressed optimism about the device’s ongoing performance in these initial cases.
Innovation in Brain-Computer Interfaces
Neuralink’s work represents a significant step forward in brain-computer interface technology, which holds transformative potential for individuals with severe mobility impairments. The addition of the feasibility study underscores the company’s commitment to refining its technology and expanding its applications.